Influenza A virus vaccine H7N9 - Adimmune CorporationAlternative Names: AdimFlu-A
Latest Information Update: 14 Dec 2015
At a glance
- Originator Adimmune Corporation
- Class Influenza A vaccines; Influenza A virus H7N9 vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Influenza A virus H7N9 subtype